Prolactin inhibition of pregnant mare's serum stimulated follicle development in the rat ovary

J. L. Larsen, A. Bhanu, W. D. Odell

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Prolactin (PRL) effects on the female reproductive system have been presumed to occur primarily at the hypothalamic-pituitary level. The following studies were designed to evaluate whether PRL can directly alter gonadotropin actions at the ovarian level. In the first experiment, 10 groups of 7 cycling adult female rats were given a daily dose of pregnant mare's serum (PMS: 25 IU) and either saline (SAL) or PRL (0.25, 0.8, 2.5, 8, or 25ug) twice daily for 4 days. In the second experiment, PMS (6 doses: 0-75 IU/d; 16 animals/dose) was administered to all animals while half the animals at each PMS dose received PRL (25ug twice daily) and half received an equal volume of diluent. Finally, hypophysectomized (hypox) adult rats (n=5-6/group) received 25 IU PMS/d and PRL (0-75 ug) twice daily. An additional group re-ceived 0 PRL and 0 PMS. Ovarian weight and histology were evaluated at the completion of each study. In the first experiment, PRL inhibited PMS-stimulated ovarian weight gain in a dose-dependent manner (p<0.01). Numbers of preantral (p<0.005) and antral (p<0.05) follicles were decreased in animals receiving an inhibitory dose of PRL (25ug BID) compared to controls. In the second experiment PRL (25 ug BID) again inhibited PMS-stimulated ovarian weight (p<0.01) at all doses of PMS. Finally, in hypox animals, PRL inhibited PMS-stimulated ovarian weight gain (25 and 75 ug PRL: p=0.001), and mean number (p<0.001) and diameter (p<0.001) of antral ovarian follicles (8-75ug PRL) compared to controls. In summary, administration of PRL inhibited PMS-stimulated ovarian weight gain, and antral follicle diameter (in hypox animals only) and number in adult female rats suggesting that in states of hyperprolactinemia, PRL alters gonadotropin-mediated activities (i.e., folliculogenesis) directly at the ovarian level in addition to its hypothalamic and pituitary actions.

Original languageEnglish (US)
Pages (from-to)449-459
Number of pages11
JournalEndocrine Research
Volume16
Issue number4
DOIs
StatePublished - Jan 1 1990

Fingerprint

Prolactin
Ovary
Serum
Weight Gain
Gonadotropins
Weights and Measures
Hyperprolactinemia
Ovarian Follicle
Histology

ASJC Scopus subject areas

  • Endocrinology

Cite this

Prolactin inhibition of pregnant mare's serum stimulated follicle development in the rat ovary. / Larsen, J. L.; Bhanu, A.; Odell, W. D.

In: Endocrine Research, Vol. 16, No. 4, 01.01.1990, p. 449-459.

Research output: Contribution to journalArticle

@article{53ad0ad19fa04e03af104d5b0f785511,
title = "Prolactin inhibition of pregnant mare's serum stimulated follicle development in the rat ovary",
abstract = "Prolactin (PRL) effects on the female reproductive system have been presumed to occur primarily at the hypothalamic-pituitary level. The following studies were designed to evaluate whether PRL can directly alter gonadotropin actions at the ovarian level. In the first experiment, 10 groups of 7 cycling adult female rats were given a daily dose of pregnant mare's serum (PMS: 25 IU) and either saline (SAL) or PRL (0.25, 0.8, 2.5, 8, or 25ug) twice daily for 4 days. In the second experiment, PMS (6 doses: 0-75 IU/d; 16 animals/dose) was administered to all animals while half the animals at each PMS dose received PRL (25ug twice daily) and half received an equal volume of diluent. Finally, hypophysectomized (hypox) adult rats (n=5-6/group) received 25 IU PMS/d and PRL (0-75 ug) twice daily. An additional group re-ceived 0 PRL and 0 PMS. Ovarian weight and histology were evaluated at the completion of each study. In the first experiment, PRL inhibited PMS-stimulated ovarian weight gain in a dose-dependent manner (p<0.01). Numbers of preantral (p<0.005) and antral (p<0.05) follicles were decreased in animals receiving an inhibitory dose of PRL (25ug BID) compared to controls. In the second experiment PRL (25 ug BID) again inhibited PMS-stimulated ovarian weight (p<0.01) at all doses of PMS. Finally, in hypox animals, PRL inhibited PMS-stimulated ovarian weight gain (25 and 75 ug PRL: p=0.001), and mean number (p<0.001) and diameter (p<0.001) of antral ovarian follicles (8-75ug PRL) compared to controls. In summary, administration of PRL inhibited PMS-stimulated ovarian weight gain, and antral follicle diameter (in hypox animals only) and number in adult female rats suggesting that in states of hyperprolactinemia, PRL alters gonadotropin-mediated activities (i.e., folliculogenesis) directly at the ovarian level in addition to its hypothalamic and pituitary actions.",
author = "Larsen, {J. L.} and A. Bhanu and Odell, {W. D.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1080/07435809009107117",
language = "English (US)",
volume = "16",
pages = "449--459",
journal = "Endocrine Research",
issn = "0743-5800",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Prolactin inhibition of pregnant mare's serum stimulated follicle development in the rat ovary

AU - Larsen, J. L.

AU - Bhanu, A.

AU - Odell, W. D.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Prolactin (PRL) effects on the female reproductive system have been presumed to occur primarily at the hypothalamic-pituitary level. The following studies were designed to evaluate whether PRL can directly alter gonadotropin actions at the ovarian level. In the first experiment, 10 groups of 7 cycling adult female rats were given a daily dose of pregnant mare's serum (PMS: 25 IU) and either saline (SAL) or PRL (0.25, 0.8, 2.5, 8, or 25ug) twice daily for 4 days. In the second experiment, PMS (6 doses: 0-75 IU/d; 16 animals/dose) was administered to all animals while half the animals at each PMS dose received PRL (25ug twice daily) and half received an equal volume of diluent. Finally, hypophysectomized (hypox) adult rats (n=5-6/group) received 25 IU PMS/d and PRL (0-75 ug) twice daily. An additional group re-ceived 0 PRL and 0 PMS. Ovarian weight and histology were evaluated at the completion of each study. In the first experiment, PRL inhibited PMS-stimulated ovarian weight gain in a dose-dependent manner (p<0.01). Numbers of preantral (p<0.005) and antral (p<0.05) follicles were decreased in animals receiving an inhibitory dose of PRL (25ug BID) compared to controls. In the second experiment PRL (25 ug BID) again inhibited PMS-stimulated ovarian weight (p<0.01) at all doses of PMS. Finally, in hypox animals, PRL inhibited PMS-stimulated ovarian weight gain (25 and 75 ug PRL: p=0.001), and mean number (p<0.001) and diameter (p<0.001) of antral ovarian follicles (8-75ug PRL) compared to controls. In summary, administration of PRL inhibited PMS-stimulated ovarian weight gain, and antral follicle diameter (in hypox animals only) and number in adult female rats suggesting that in states of hyperprolactinemia, PRL alters gonadotropin-mediated activities (i.e., folliculogenesis) directly at the ovarian level in addition to its hypothalamic and pituitary actions.

AB - Prolactin (PRL) effects on the female reproductive system have been presumed to occur primarily at the hypothalamic-pituitary level. The following studies were designed to evaluate whether PRL can directly alter gonadotropin actions at the ovarian level. In the first experiment, 10 groups of 7 cycling adult female rats were given a daily dose of pregnant mare's serum (PMS: 25 IU) and either saline (SAL) or PRL (0.25, 0.8, 2.5, 8, or 25ug) twice daily for 4 days. In the second experiment, PMS (6 doses: 0-75 IU/d; 16 animals/dose) was administered to all animals while half the animals at each PMS dose received PRL (25ug twice daily) and half received an equal volume of diluent. Finally, hypophysectomized (hypox) adult rats (n=5-6/group) received 25 IU PMS/d and PRL (0-75 ug) twice daily. An additional group re-ceived 0 PRL and 0 PMS. Ovarian weight and histology were evaluated at the completion of each study. In the first experiment, PRL inhibited PMS-stimulated ovarian weight gain in a dose-dependent manner (p<0.01). Numbers of preantral (p<0.005) and antral (p<0.05) follicles were decreased in animals receiving an inhibitory dose of PRL (25ug BID) compared to controls. In the second experiment PRL (25 ug BID) again inhibited PMS-stimulated ovarian weight (p<0.01) at all doses of PMS. Finally, in hypox animals, PRL inhibited PMS-stimulated ovarian weight gain (25 and 75 ug PRL: p=0.001), and mean number (p<0.001) and diameter (p<0.001) of antral ovarian follicles (8-75ug PRL) compared to controls. In summary, administration of PRL inhibited PMS-stimulated ovarian weight gain, and antral follicle diameter (in hypox animals only) and number in adult female rats suggesting that in states of hyperprolactinemia, PRL alters gonadotropin-mediated activities (i.e., folliculogenesis) directly at the ovarian level in addition to its hypothalamic and pituitary actions.

UR - http://www.scopus.com/inward/record.url?scp=0025543751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025543751&partnerID=8YFLogxK

U2 - 10.1080/07435809009107117

DO - 10.1080/07435809009107117

M3 - Article

C2 - 2102466

AN - SCOPUS:0025543751

VL - 16

SP - 449

EP - 459

JO - Endocrine Research

JF - Endocrine Research

SN - 0743-5800

IS - 4

ER -